Cargando…
Metformin Can Attenuate Beta-Cell Hypersecretion—Implications for Treatment of Children with Obesity
In children with obesity, insulin hypersecretion is proposed to precede insulin resistance. We investigated if metformin could be used to attenuate insulin secretion from palmitate-treated isolated islets and its implication for children with obesity. Human islets were exposed to palmitate for 0.5 o...
Autores principales: | Wen, Quan, Stenlid, Rasmus, Chowdhury, Azazul Islam, Ciba, Iris, Aydin, Banu, Cerenius, Sara Y., Manell, Hannes, Forslund, Anders, Bergsten, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456302/ https://www.ncbi.nlm.nih.gov/pubmed/37623862 http://dx.doi.org/10.3390/metabo13080917 |
Ejemplares similares
-
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
por: Stenlid, Rasmus, et al.
Publicado: (2023) -
High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition
por: Aydin, Banu Kucukemre, et al.
Publicado: (2022) -
Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
por: Stenlid, Rasmus, et al.
Publicado: (2023) -
Altered mitochondrial metabolism in peripheral blood cells from patients with inborn errors of β‐oxidation
por: Stenlid, Rasmus, et al.
Publicado: (2021) -
Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
por: Kristinsson, H., et al.
Publicado: (2017)